Trident Pharmaceuticals Obtains $275,187 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=28d3de52-7223-4994-ab7d-ad915a57ed76
Date
5/22/2014
Company Name
Trident Pharmaceuticals
Mailing Address
184 High Street Boston, MA 02110 USA
Company Description
Trident Pharmaceuticals, founded in 2006, is dedicated to the development of novel immunomodulatory drug products for the treatment of inflammatory and autoimmune disorders and allergic conditions.
Website
http://www.tridentpharma.com
Transaction Type
Venture Equity
Transaction Amount
$275,187
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor